Detection of Pelvic Lymph Node Metastases in Patients With Clinically Localized Prostate Cancer: Comparison of [18F]Fluorocholine Positron Emission Tomography-Computerized Tomography and Laparoscopic Radioisotope Guided Sentinel Lymph Node Dissection

Journal of Urology

Volumn 176, Issue 5, 2006, Pages 2014-2019

  Häcker, Axel ^a,b   Jeschke, Stefan ^a   Leeb, Karl ^a   Prammer, Kurt ^a   Ziegerhofer, Josef ^a   Sega, Wolfgang ^a   Langsteger, Werner ^a   Janetschek, Guenter ^a  

^a Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

laparoscopy; lymphatic metastasis; positron emission tomography; prostatectomy; prostatic neoplasms

Indexed keywords

FLUOROCHOLINE F 18; IASOCHOLINE; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FALSE POSITIVE RESULT; GLEASON SCORE; HUMAN; ILIAC ARTERY; ILIAC VEIN; INTERNAL ILIAC ARTERY; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SENTINEL LYMPH NODE;

AGED; CHOLINE; HUMANS; LAPAROSCOPY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750335180     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.07.037     Document Type: Article

References (20)

1. Messing E.M., Manola J., Sarosdy M., Wilding G., Crawford E.D., and Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781
2. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514
3. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849
4. Allaf M.E., Palapattu G.S., Trock B.J., Carter H.B., and Walsh P.C. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172 (2004) 1840
5. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 (2002) 1681
6. Wawroschek F., Vogt H., Weckermann D., Wagner T., Hamm M., and Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 166 (2001) 1715
7. Jeschke S., Nambirajan T., Leeb K., Ziegerhofer J., Sega W., and Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 173 (2005) 1943
8. Schmid D.T., John H., Zweifel R., Cservenyak T., Westera G., and Goerres G.W. Fluorocholine PET-CT in patients with prostate cancer: initial experience. Radiology 235 (2005) 623
9. Nader M., and Hoepping A. Metamorphosis of a dedicated FDG disposable kit module to a multipurpose synthesizer. Nuklearmedizin 44 (2005) A192 abstract 7
10. Vassiliev D., Krasikova R., Kutznetsova O., Federova O., and Nader M. Simple HPLC method for the detection of N, N-dimethylaminoethanol in the preparation of [N-methyl-11C]choline. Eur J Nucl Med 30 (2003) 342P
11. Langsteger W., Heinisch M., and Fogelmann I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 36 (2006) 73
12. Partin A.W., Kattan M.W., Subong E.N., Walsh P.C., Wojno K.J., and Oesterling J.E. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445
13. Ghavamian R., Blute M.L., Bergstralh E.J., Slezak J., and Zincke H. Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. Urology 54 (1999) 105
14. Brossner C., Ringhofer H., Hernady T., Kuber W., Madersbacher S., and Pycha A. Lymphatic drainage of prostatic transition and peripheral zones visualized on a three-dimensional workstation. Urology 57 (2001) 389
15. Burkhard F.C., Bader P., Schneider E., Markwalder R., and Studer U.E. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol 42 (2002) 84
16. Clark T., Parekh D.J., Cookson M.S., Chang S.S., Smith Jr. E.R., and Wells N. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145
17. Yoshida S., Nakagomi K., Goto S., Futatsubashi M., and Torizuka T. 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging. Urol Int 74 (2005) 214
18. Wawroschek F., Vogt H., Wengenmair H., Weckermann D., Hamm M., and Keil M. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 70 (2003) 303
19. Brenot-Rossi I., Bastide C., Garcia S., Dumas S., Esterni B., and Pasquier J. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 32 (2005) 635
20. Takashima H., Egawa M., Imao T., Fukuda M., Yokoyama K., and Namiki M. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 171 (2004) 2268